BioPharma

29 May, 2023 | Monday | News

Pfizer's PAXLOVID™ FDA-approved for high-risk adults with severe COVID-19

PAXLOVID is the first FDA-approved oral treatment for COVID-19; has been authorized for emergency use since December 2021 Approval is based on the totality of scientific evidence submitted, including efficac...

Lab

31 May, 2023 | Wednesday | News

Guardant Health's Guardant360® CDx Blood Test Approved by Singapore Health Authority for Advanced Solid Cancers

Guardant360® CDx is a comprehensive genomic profiling blood test that provides critical information to help inform personalized treatment decisions for patients with advanced solid cancers   Th...

BioTech

31 May, 2023 | Wednesday | News

Luzhu Biotechnology's LZ901 Completes Phase II Clinical Trial for Herpes Zoster Vaccine

Beijing Luzhu Biotechnology Co., Ltd. ("Luzhu Biotechnology" or the "Company", together with its subsidiaries, the "Group", stock code: 02480.HK), a leading vaccine and antibody drug developer in Chin...

Contract Services

25 May, 2023 | Thursday | News

Catalent Enhances Cryogenic Capabilities in Japan Facility for Cell and Gene Therapy Development

State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational advanced therapy products by minimizing their time-out-...

Consumer Health

30 May, 2023 | Tuesday | News

Hospital-Based Health Technology Assessment: Global Experience and Vietnam's Situation

From the perception and vision, from May 26th to May 27th, Hong Bang International University (HIU) collaborated with the Vietnam Medical Association and the Health Technology Assessment and Appl...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close